Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease
- PMID: 15851645
- DOI: 10.1001/archinte.165.8.923
Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease
Abstract
Background: Many cases of end-stage renal disease (ESRD) are ascribed to hypertension. However, because renal disease itself can raise blood pressure, some investigators argue that ESRD seen in patients with hypertension is due to underlying primary renal disease. Previous cohort studies of the relationship between blood pressure and ESRD did not uniformly screen out baseline kidney disease.
Methods: We conducted a historical cohort study among members of Kaiser Permanente of Northern California, a large integrated health care delivery system. The ESRD cases were ascertained by matching with the US Renal Data System registry.
Results: A total of 316 675 adult Kaiser members participated in the Multiphasic Health Checkups from 1964 to 1985. All subjects had estimated glomerular filtration rates of 60 mL /min per 1.73 m(2) or higher and negative dipstick urinalysis results for proteinuria or hematuria. During 8 210 431 person-years of follow-up, 1149 cases of ESRD occurred. Compared with subjects with a blood pressure less than 120/80 mm Hg, the adjusted relative risks for developing ESRD were 1.62 (95% confidence interval [CI], 1.27-2.07) for blood pressures of 120 to 129/80 to 84 mm Hg, 1.98 (95% CI, 1.55-2.52) for blood pressures of 130 to 139/85 to 89 mm Hg, 2.59 (95% CI, 2.07-3.25) for blood pressures of 140 to 159/90 to 99 mm Hg, 3.86 (95% CI, 3.00-4.96) for blood pressures of 160 to 179/100 to 109 mm Hg, 3.88 (95% CI, 2.82-5.34) for blood pressures of 180 to 209/110 to 119 mm Hg, and 4.25 (95% CI, 2.63-6.86) for blood pressures of 210/120 mm Hg or higher. Similar associations between blood pressure level and ESRD risk were seen in all subgroup analyses.
Conclusions: Even relatively modest elevation in blood pressure is an independent risk factor for ESRD. The observed relationship does not appear to be due to confounding by clinically evident baseline kidney disease.
Similar articles
-
Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).Arch Intern Med. 2005 Apr 25;165(8):936-46. doi: 10.1001/archinte.165.8.936. Arch Intern Med. 2005. PMID: 15851647 Clinical Trial.
-
Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial.J Am Soc Nephrol. 2006 May;17(5):1444-52. doi: 10.1681/ASN.2005091012. Epub 2006 Apr 12. J Am Soc Nephrol. 2006. PMID: 16611715 Clinical Trial.
-
Prehypertension, obesity, and risk of kidney disease: 20-year follow-up of the HUNT I study in Norway.Am J Kidney Dis. 2009 Oct;54(4):638-46. doi: 10.1053/j.ajkd.2009.03.023. Epub 2009 Jun 10. Am J Kidney Dis. 2009. PMID: 19515474
-
Ambulatory blood pressure during diseases of the kidney.Blood Press Monit. 1999 Oct;4(5):267-74. Blood Press Monit. 1999. PMID: 10547649 Review.
-
Treatment of hypertension in chronic kidney disease.Semin Nephrol. 2005 Nov;25(6):435-9. doi: 10.1016/j.semnephrol.2005.05.016. Semin Nephrol. 2005. PMID: 16298269 Review.
Cited by
-
Most important outcomes research papers on hypertension.Circ Cardiovasc Qual Outcomes. 2013 Jul;6(4):e26-35. doi: 10.1161/CIRCOUTCOMES.113.000424. Epub 2013 Jul 9. Circ Cardiovasc Qual Outcomes. 2013. PMID: 23838106 Free PMC article. Review.
-
Emerging drug combinations to optimize renovascular protection and blood pressure goals.Int J Nephrol Renovasc Dis. 2012;5:69-80. doi: 10.2147/IJNRD.S7048. Epub 2012 Apr 3. Int J Nephrol Renovasc Dis. 2012. PMID: 22536084 Free PMC article.
-
Relationship between blood pressure and kidney diseases in large randomized controlled trials: secondary analyses using SPRINT and ACCORD-BP trials.J Hum Hypertens. 2021 Oct;35(10):859-869. doi: 10.1038/s41371-020-00430-2. Epub 2020 Oct 22. J Hum Hypertens. 2021. PMID: 33093616
-
How "pre" is prehypertension?Curr Hypertens Rep. 2007 Jun;9(3):173-4. doi: 10.1007/s11906-007-0031-5. Curr Hypertens Rep. 2007. PMID: 17519120 No abstract available.
-
Ambulatory blood pressure as risk factor for long-term kidney function decline in the general population: a distributional regression approach.Sci Rep. 2023 Aug 31;13(1):14296. doi: 10.1038/s41598-023-41181-7. Sci Rep. 2023. PMID: 37652955 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical